Provided by Tiger Fintech (Singapore) Pte. Ltd.

Argenx SE

596.20
+8.611.47%
Post-market: 596.200.00000.00%18:14 EDT
Volume:321.81K
Turnover:191.68M
Market Cap:36.36B
PE:46.65
High:601.27
Open:590.90
Low:590.60
Close:587.59
Loading ...

Oppenheimer Adjusts argenx SE ADR Price Target to $675 From $646, Maintains Outperform Rating

MT Newswires Live
·
22 Nov 2024

Argenx price target raised to $706 from $675 at Evercore ISI

TIPRANKS
·
21 Nov 2024

Oppenheimer Reaffirms Their Buy Rating on Argenx Se (ARGX)

TIPRANKS
·
21 Nov 2024

Positive Clinical Trial Results and Market Position Strengthen Buy Rating for Argenx SE

TIPRANKS
·
21 Nov 2024

argenx Price Target Maintained With a $617.00/Share by HC Wainwright & Co.

Dow Jones
·
21 Nov 2024

Argenx may have first targeted myositis treatment, says H.C. Wainwright

TIPRANKS
·
21 Nov 2024

Sector Update: Health Care Stocks Edge Higher Premarket Wednesday

MT Newswires Live
·
20 Nov 2024

Argenx Se (ARGX) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
20 Nov 2024

Argenx to Continue Development of Autoimmune Disease Drug After Phase 2/3 Data

MT Newswires Live
·
20 Nov 2024

Argenx to continue development of efgartigimod subcutaneous

TIPRANKS
·
20 Nov 2024

Is argenx SE (ARGX) the Best Immunotherapy Stock to Buy Now?

Insider Monkey
·
18 Nov 2024

Argenx Se (ARGX) Gets a Buy from Truist Financial

TIPRANKS
·
18 Nov 2024

Morgan Stanley Raises Price Target on argenx to $675 From $580, Keeps Overweight Rating

MT Newswires Live
·
18 Nov 2024

European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week

MT Newswires Live
·
16 Nov 2024

Argenx and Zai Lab’s CIDP Drug Approved in China

TIPRANKS
·
12 Nov 2024

Wolfe Research Upgrades argenx SE ADR to Outperform From Peer Perform, $697 Price Target

MT Newswires Live
·
12 Nov 2024

Argenx upgraded to Outperform from Peer Perform at Wolfe Research

TIPRANKS
·
12 Nov 2024

Zai Lab, Argenx Receive Chinese Approval for Neuromuscular Drug Vyvgart Hytrulo

MT Newswires Live
·
11 Nov 2024

Argenx, Zai Lab announce approval of VYVGART Hytrulo in China

TIPRANKS
·
11 Nov 2024

Why Argenx (ARGX) Might be Well Poised for a Surge

Zacks
·
06 Nov 2024